Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

UK Biobank has today announced the launch of the world's most comprehensive study of the proteins circulating in our bodies, ...

A groundbreaking study analyzing how levels of up to 5,400 proteins circulating in our body change in mid-to-late life and ...

Research led by Queen Mary’s Professor Claudia Langenberg and her team has helped to prove the effectiveness of large-scale ...

UK Biobank is the world's most comprehensive source of biomedical data available for health research in the public interest. In 2023 it released data ...

Thermo Fisher (TMO) announced the UK Biobank Pharma Proteomics Project, or UKB-PPP, has selected its Olink Explore Platform to support the ...

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma ...

Tens of millions of pounds in investment is being provided by the group of firms which includes AstraZenecaa and Pfizer ...

UK Biobank has today announced the launch of the world's most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter "Meiji") announced that the company has concluded an investment agreement ...